National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 66717-66718 [2022-24059]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 213 / Friday, November 4, 2022 / Notices
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
website, www.diabetescommittee.gov.
William T. Cefalu,
Director, Division of Diabetes, Endocrinology,
and Metabolic Diseases, National Institute of
Diabetes and Digestive and Kidney Diseases,
and Metabolic Diseases, National Institutes
of Health.
[FR Doc. 2022–24087 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, Small
Business: Biological Chemistry,
Biophysics, and Assay Development,
November 15–16, 2022, 9:00 a.m. to 5:00
p.m., The Bethesdan Hotel Tapestry
Collection by Hilton (Formerly Holiday
Inn Select), 8120 Wisconsin Avenue,
Bethesda, MD 20814, which was
published in the Federal Register on
October 20, 2022, 87 FR 63790, Doc
2022–22763.
This meeting is being amended to
change the meeting start time from 9:00
a.m. to 8:30 a.m. The meeting is closed
to the public.
Dated: November 1, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24061 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:12 Nov 03, 2022
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Immunology and Infectious
Diseases C.
Date: December 1–2, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shannon J. Sherman,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
MD 20892, 301–594–0715,
shannon.sherman@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Special
Topics in Biomaterials, Biointerfaces, Gene
and Drug Delivery.
Date: December 2, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joseph D. Mosca, BA,
Ph.D., MBA, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5158, MSC 7808, Bethesda, MD 20892,
(301) 408–9465, moscajos@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Maternal and Pediatric Pharmacology and
Therapeutics.
Date: December 2, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
66717
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 31, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24033 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Division of Intramural
Research Board of Scientific Counselors,
NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE OF ALLERGY
AND INFECTIOUS DISEASES,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Division of Intramural
Research Board of Scientific Counselors,
NIAID.
Date: December 12–14, 2022.
Time: 7:45 a.m. to 10:15 a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, Building 50, Conference Room 1227/
1233, 50 Center Drive, Bethesda, MD 20892.
Contact Person: Laurie Lewallen,
Committee Manager, Division of Intramural
Research Program Support Staff, National
Institute of Allergy and Infectious Diseases,
National Institutes of Health, Building 33,
Room 1N24, 33 North Drive, Bethesda, MD
20892, 301–761–6362, Laurie.Lewallen@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\04NON1.SGM
04NON1
66718
Federal Register / Vol. 87, No. 213 / Friday, November 4, 2022 / Notices
Dated: November 1, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24059 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Investigator
Initiated Program Project Applications
(P01 Clinical Trial Not Allowed) which
was published in the Federal Register
on October 28, 2022, FR Doc 2022–
23540, 87 FR 65215.
Amendment to change meeting date
and time from November 14, 2022, at
2:00 p.m. to 5:00 p.m. to November 15,
2022, at 1:00 p.m. to 4:00 p.m. The
meeting is closed to the public.
Dated: November 1, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–24060 Filed 11–3–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket ID: FEMA–2022–0035; OMB No.
1660–0115]
Agency Information Collection
Activities: Proposed Collection;
Comment Request; Environmental and
Historic Preservation Screening Form
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: 60-Day notice of revision and
request for comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA), as part of
its continuing effort to reduce
paperwork and respondent burden,
invites the general public and other
Federal agencies to take this
opportunity to comment on an
extension, with change, of a currently
approved information collection. In
accordance with the Paperwork
Reduction Act of 1995, this notice seeks
khammond on DSKJM1Z7X2PROD with NOTICES
VerDate Sep<11>2014
18:12 Nov 03, 2022
Jkt 259001
Beth
McWaters-Bjorkman, Environmental
Protection Specialist, FEMA, Grant
Programs Directorate, 202–431–8594,
elizabeth.mcwaters-bjorkman@
fema.dhs.gov. You may contact the
Records Management Division for
copies of the proposed collection of
information at email address: FEMAInformation-Collections-Management@
fema.dhs.gov.
FOR FURTHER INFORMATION CONTACT:
FEMA’s
Grant Programs Directorate (GPD)
awards thousands of grants each year
through various grant programs. These
programs award funds for projects used
to improve homeland security and
emergency preparedness. The National
Environmental Policy Act of 1969
(NEPA), Public Law 91–190, sec. 102 (B)
and (C), 42 U.S.C. 4332, the National
Historic Preservation Act of 1966
(NHPA), Public Law 89–665, 16 U.S.C.
470f, the Endangered Species Act of
1973, Public Law 93–205, 16 U.S.C.
1531 et seq., and a variety of other
environmental and historic preservation
laws and Executive Orders (E.O.)
require the Federal Government to
examine the potential environmental
impacts of its proposed actions on
communities, public health and safety,
and cultural, historic, and natural
resources including endangered and
threatened species prior to
implementing those actions. The GPD
process of considering these potential
impacts is called an environmental and
historic preservation (EHP) review
which is employed to achieve
SUPPLEMENTARY INFORMATION:
Federal Emergency Management
Agency
SUMMARY:
comments concerning the information
collection activities required to
administer the Environmental and
Historic Preservation Environmental
Screening Form.
DATES: Comments must be submitted on
or before January 3, 2023.
ADDRESSES: To avoid duplicate
submissions to the docket, please
submit comments at
www.regulations.gov under Docket ID
FEMA–2022–0035. Follow the
instructions for submitting comments.
All submissions received must
include the agency name and Docket ID.
Regardless of the method used for
submitting comments or material, all
submissions will be posted, without
change, to the Federal eRulemaking
Portal at https://www.regulations.gov,
and will include any personal
information you provide. Therefore,
submitting this information makes it
public. You may wish to read the
Privacy Act notice that is available via
the link in the footer of
www.regulations.gov.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
compliance with multiple EHP
authorities through one consolidated
process.
With input from recipients, FEMA is
proposing to revise the EHP Screening
Form for clarity and ease of use. The
2022 EHP Screening Form does not
require any new information and
includes an appendix with guidance on
providing photographs with the EHP
submission. Recipients are no longer
required to submit Authorized
Equipment List (AEL) numbers.
Collection of Information
Title: Environmental and Historic
Preservation Screening Form.
Type of Information Collection:
Extension, with change, of a currently
approved information collection.
OMB Number: 1660–0115.
FEMA Forms: FEMA Form FF–119–
FY–21–105 (formerly 024–0–1),
Environmental and Historic
Preservation Screening Form.
Abstract: The National Environmental
Policy Act of 1969 (NEPA) requires that
each Federal agency examine the impact
of a major Federal action (including the
actions of recipients using grant funds)
significantly affecting the quality of the
human environment. This involves
considering the environmental impact
of the proposed action, alternatives to
the proposed action, informing both
decision-makers and the public of the
impacts through a transparent process,
and identifying mitigation measures for
any potential adverse impacts (40 CFR
1500.1, 1501.5 and 1501.6). Among
other environmental laws, the review
also involves considering the effects of
the undertaking on historic properties
under Section 106 of the National
Historic Preservation Act and the effects
of the action on any threatened or
endangered species and their habitat
under Section 7 of the Endangered
Species Act of 1973. This Screening
Form will facilitate the Federal
Emergency Management Agency’s
(FEMA’s) review of recipient Federallyfunded actions in FEMA’s effort to
comply with the environmental
requirements.
Affected Public: State, local or Tribal
government; Not-for-Profit Institutions.
Estimated Number of Respondents:
2,300.
Estimated Number of Responses:
2,300.
Estimated Total Annual Burden
Hours: 16,752.
Estimated Total Annual Respondent
Cost: $1,039,877.
Estimated Respondents’ Operation
and Maintenance Costs: $0.
Estimated Respondents’ Capital and
Start-Up Costs: $0.
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Pages 66717-66718]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24059]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Division of
Intramural Research Board of Scientific Counselors, NIAID.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the NATIONAL
INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Division of Intramural Research Board of
Scientific Counselors, NIAID.
Date: December 12-14, 2022.
Time: 7:45 a.m. to 10:15 a.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Building 50, Conference Room 1227/
1233, 50 Center Drive, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Committee Manager, Division of
Intramural Research Program Support Staff, National Institute of
Allergy and Infectious Diseases, National Institutes of Health,
Building 33, Room 1N24, 33 North Drive, Bethesda, MD 20892, 301-761-
6362, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 66718]]
Dated: November 1, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-24059 Filed 11-3-22; 8:45 am]
BILLING CODE 4140-01-P
